93 related articles for article (PubMed ID: 6697576)
1. Prospective study of natural cytotoxicity in peripheral blood of patients with nonlymphoid solid malignancies.
Stewart LD; Ades EW
Clin Immunol Immunopathol; 1984 Apr; 31(1):78-86. PubMed ID: 6697576
[TBL] [Abstract][Full Text] [Related]
2. Early effects of radium therapy on natural killer (NK) activity in patients with gynaecological malignancies.
Frydecka I; Blok K; Kornafel J; Kuliczkowaski K; Polakowska A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(4):499-505. PubMed ID: 2431971
[TBL] [Abstract][Full Text] [Related]
3. Natural cytotoxicity and serum blocking in malignant cervical neoplasia.
Pillai MR; Balaram P; Abraham T; Padmanabhan TK; Nair MK
Am J Reprod Immunol Microbiol; 1988 Apr; 16(4):159-62. PubMed ID: 3421407
[TBL] [Abstract][Full Text] [Related]
4. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
5. Clinical implications of natural killer (NK) cytotoxicity in patients with squamous cell carcinoma of the uterine cervix.
Vaquer S; Jordá J; López de la Osa E; Alvarez de los Heros J; López-García N; Alvarez de Mon M
Gynecol Oncol; 1990 Jan; 36(1):90-2. PubMed ID: 2295458
[TBL] [Abstract][Full Text] [Related]
6. Phenotype and function of natural killer cells in patients with bronchogenic carcinoma.
LeFever AV; Funahashi A
Cancer Res; 1991 Oct; 51(20):5596-601. PubMed ID: 1655257
[TBL] [Abstract][Full Text] [Related]
7. Natural killer (NK) activity in peripheral blood lymphocytes of patients with benign and malignant breast disease.
White D; Jones DB; Cooke T; Kirkham N
Br J Cancer; 1982 Oct; 46(4):611-6. PubMed ID: 7138766
[TBL] [Abstract][Full Text] [Related]
8. The relationship of chemotherapeutic and endocrine intervention on natural killer cell activity in human breast cancer.
Brenner BG; Margolese RG
Cancer; 1991 Aug; 68(3):482-8. PubMed ID: 2065267
[TBL] [Abstract][Full Text] [Related]
9. miR-20a inhibits the killing effect of natural killer cells to cervical cancer cells by downregulating RUNX1.
Zhu SY; Wu QY; Zhang CX; Wang Q; Ling J; Huang XT; Sun X; Yuan M; Wu D; Yin HF
Biochem Biophys Res Commun; 2018 Oct; 505(1):309-316. PubMed ID: 30249397
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cells and interleukin-12 in patients with advanced cervical cancer under neoadjuvant chemotherapy.
Marana HR; Andrade JM; Silva JS
Braz J Med Biol Res; 1996 Apr; 29(4):473-7. PubMed ID: 8736110
[TBL] [Abstract][Full Text] [Related]
11. [Factors influencing depression of natural killer activity and its prevention in esophageal cancer patients].
Zeze K; Saito T; Kobayashi M
Nihon Geka Gakkai Zasshi; 1989 Jan; 90(1):22-33. PubMed ID: 2704363
[TBL] [Abstract][Full Text] [Related]
12. Human breast cancer and impaired NK cell function.
Garner WL; Minton JP; James AG; Hoffmann CC
J Surg Oncol; 1983 Sep; 24(1):64-6. PubMed ID: 6887939
[TBL] [Abstract][Full Text] [Related]
13. Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer.
Baxevanis CN; Reclos GJ; Gritzapis AD; Dedousis GV; Missitzis I; Papamichail M
Cancer; 1993 Jul; 72(2):491-501. PubMed ID: 8319179
[TBL] [Abstract][Full Text] [Related]
14. Effect of bitter melon (Momordica charantia Linn) on level and function of natural killer cells in cervical cancer patients with radiotherapy.
Pongnikorn S; Fongmoon D; Kasinrerk W; Limtrakul PN
J Med Assoc Thai; 2003 Jan; 86(1):61-8. PubMed ID: 12678140
[TBL] [Abstract][Full Text] [Related]
15. [Correlation of NK cell activity against autologous tumour cells and K562 cells with the clinical outcome during therapy with mistletoe extracts].
Schink M; Tröger W; Goyert A; Scheuerecker H; Selbmann HK; Glaser F
Forsch Komplementmed; 2006 Jun; 13(3):147-55. PubMed ID: 16868360
[TBL] [Abstract][Full Text] [Related]
16. Studies of natural killer activity and augmentation by OK-432 in patients with gynecological malignancies.
Negishi Y; Miura M; Saito M; Sano Y; Akiya K; Fujiwara Y
Gynecol Obstet Invest; 1986; 21(1):40-6. PubMed ID: 3485072
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cell activity and recycling capacity of natural killer cells in patients with carcinoma of the prostate.
Marumo K; Ikeuchi K; Baba S; Ueno M; Tazaki H
Keio J Med; 1989 Mar; 38(1):27-35. PubMed ID: 2716216
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cells in children with malignant solid tumors. Effect of recombinant interferon-alpha and interleukin-2 on natural killer cell function against tumor cell lines.
Alvarado CS; Findley HW; Chan WC; Hnath RS; Abdel-Mageed A; Pais RC; Kutner MH; Ragab AH
Cancer; 1989 Jan; 63(1):83-9. PubMed ID: 2783377
[TBL] [Abstract][Full Text] [Related]
19. NK cell activity in the presence of IL-12 is a prognostic assay to neoadjuvant chemotherapy in cervical cancer.
Cosiski Marana HR; Santana da Silva J; Moreira de Andrade J
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):318-23. PubMed ID: 10985887
[TBL] [Abstract][Full Text] [Related]
20. Peripheral blood natural killer cell activity in human breast cancer patients and its modulation by T-cell growth factor and autologous plasma.
Brenner BG; Benarrosh S; Margolese RG
Cancer; 1986 Aug; 58(4):895-902. PubMed ID: 3487379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
